Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AVCP
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
AVCP (crude polysaccharides from abalone viscera) is a natural extract being investigated for its hypolipidemic and anti-atherogenic properties. Studies have shown that AVCP can significantly reduce total cholesterol, triglycerides, and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol in plasma. Additionally, it has been observed to increase superoxide dismutase activities and prevent the formation of lipid droplets and disordered liver structure, suggesting a role in combating oxidative stress and liver damage associated with hyperlipidemia and atherosclerosis.
- Other names
- crude polysaccharides from abalone viscera
02
Targets
Misfolded SOD1HDL (High-density lipoprotein)
Beyond the preview
Go deeper on AVCP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AVCP.